These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 218105)

  • 21. [Influence of lithium hydroxybutyrate on the electroencephalographic effects of fenamin].
    Saratikov AS; Zamoshchina TA; Alekseeva LP; Agarkova VP
    Biull Eksp Biol Med; 1982 Jul; 94(7):46-9. PubMed ID: 6289931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical studies with naloxone/methadone in a ratio of 1:20.
    Bloom WA; Sudderth EW; Marcello L
    Proc Natl Conf Methadone Treat; 1973; 2():1342-9. PubMed ID: 4612372
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of dynorphin-selective Kappa receptors in mouse vas deferens and guinea pig ileum. Spare receptor fraction as a determinant of potency.
    Cox BM; Chavkin C
    Mol Pharmacol; 1983 Jan; 23(1):36-43. PubMed ID: 6135144
    [No Abstract]   [Full Text] [Related]  

  • 24. Lithium attenuates the activation-euphoria but not the psychosis induced by d-amphetamine in schizophrenia.
    van Kammen DP; Docherty JP; Marder SR; Rosenblatt JE; Bunney WE
    Psychopharmacology (Berl); 1985; 87(1):111-5. PubMed ID: 3933028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methadone and naloxone in combination (Naldone) for the treatment of heroin addicts.
    Caruso FS; Gordon M; Pachter IJ
    Proc Natl Conf Methadone Treat; 1973; 2():1336-41. PubMed ID: 4215978
    [No Abstract]   [Full Text] [Related]  

  • 26. Buprenorphine misuse among heroin and amphetamine users in Malmo, Sweden: purpose of misuse and route of administration.
    Hakansson A; Medvedeo A; Andersson M; Berglund M
    Eur Addict Res; 2007; 13(4):207-15. PubMed ID: 17851242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Action on the emotional-reinforcement systems of the brain as a means of pathogenetic therapy for alcoholism and drug addiction].
    Val'dman AV; Zvartau EE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(7):1020-4. PubMed ID: 7191188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynorphin inhibition of opiate binding: specificity and reversibility in vitro.
    Garzón J; Sánchez-Blázquez P; Lee NM
    Proc West Pharmacol Soc; 1983; 26():299-303. PubMed ID: 6136980
    [No Abstract]   [Full Text] [Related]  

  • 29. [Etiologic and therapeutic significance of endorphins in endogenous psychoses].
    Naber D
    Nervenarzt; 1983 Nov; 54(11):573-7. PubMed ID: 6318141
    [No Abstract]   [Full Text] [Related]  

  • 30. Blocking effect of naloxone, dihydroergotamine and adrenalectomy in lithium-induced hyperglycaemia and glucose intolerance in the rat.
    Fontela T; García Hermida O; Gómez-Acebo J
    Acta Endocrinol (Copenh); 1986 Mar; 111(3):342-8. PubMed ID: 2870599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioural effects of opioid peptides.
    Koob GF; Bloom FE
    Br Med Bull; 1983 Jan; 39(1):89-94. PubMed ID: 6340789
    [No Abstract]   [Full Text] [Related]  

  • 32. Pyridoxine (Vit. B6) decreases opioids-induced hyperprolactinemia.
    Vescovi PP; Gerra G; Rastelli G; Ceresini G; Moccia G
    Horm Metab Res; 1985 Jan; 17(1):46-7. PubMed ID: 3967846
    [No Abstract]   [Full Text] [Related]  

  • 33. Regulation of prolactin release by endogenous opiates.
    Grandison L; Guidotti A
    Nature; 1977 Nov; 270(5635):357-9. PubMed ID: 201861
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug addiction: light at the end of the tunnel.
    Lynch JP; Fertziger AP
    J Nerv Ment Dis; 1977 Apr; 164(4):229-30. PubMed ID: 191565
    [No Abstract]   [Full Text] [Related]  

  • 35. Decrease in serum prolactin by naloxone: evidence against antidopamine and antipsychotic effects.
    Gold MS; Pottash AL; Extein I; Redmond DE; Kleber HD
    Am J Psychiatry; 1979 Oct; 136(10):1339-40. PubMed ID: 114063
    [No Abstract]   [Full Text] [Related]  

  • 36. Endorphins: physiology and clinical implications.
    Goldstein A
    Ann N Y Acad Sci; 1978; 311():49-58. PubMed ID: 217294
    [No Abstract]   [Full Text] [Related]  

  • 37. Does lithium block the effects of amphetamine? A report of three cases.
    Flemenbaum A
    Am J Psychiatry; 1974 Jul; 131(7):820-1. PubMed ID: 4834820
    [No Abstract]   [Full Text] [Related]  

  • 38. Lithium: effects on subjective functioning and morphine-induced euphoria.
    Jasinski DR; Nutt JG; Haertzen CA; Griffith JD; Bunney WE
    Science; 1977 Feb; 195(4278):582-4. PubMed ID: 319532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral effects of dynorphin -- a novel opioid neuropeptide.
    Katz RJ
    Neuropharmacology; 1980 Aug; 19(8):801-3. PubMed ID: 6106908
    [No Abstract]   [Full Text] [Related]  

  • 40. In vivo and in vitro studies of opiates and cellular immunity in narcotic addicts.
    Novick DM; Ochshorn M; Kreek MJ
    Adv Exp Med Biol; 1991; 288():159-70. PubMed ID: 1950730
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.